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Ewing's sarcomaWe aimed to investigate single nucleotide polymorphisms (SNPs) in the EWS gene breaking region in order to
analyze Ewing's sarcoma susceptibility. The SNPs were investigated in a healthy subject population and in
Ewing's sarcoma patients from Southern Brazil. Genotyping was performed by TaqMan® assay for allelic dis-
crimination using Real-Time PCR. The analysis of incidence of SNPs or different SNP-arrangements revealed a
higher presence of homozygote TT-rs4820804 in Ewing's sarcoma patients (p=0.02; Chi Square Test). About
300 bp from the rs4820804 SNP lies a palindromic hexamer (5′-GCTAGC-3′) and three nucleotides (GTC),
which were previously identiﬁed to be in close vicinity of the breakpoint junction in both EWS and FLI1
genes. This DNA segment surrounding the rs4820804 SNP is likely to indicate a breakpoint region. If the
T-rs4820804 allele predisposes a DNA fragment to breakage, homozygotes (TT-rs4820804) would have
double the chance of having a chromosome break, increasing the chances for a translocation to occur. In
conclusion, the TT-rs4820804 EWS genotype can be associated with Ewing's sarcoma and the SNP
rs4820804 can be a candidate marker to understand Ewing's sarcoma susceptibility.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Ewing's sarcoma (EWSR1, OMIM ID: 612219), a highly malignant
and metastatic sarcoma that primarily affects bone and soft tissues
(Randall et al., 2010), was ﬁrst described by James Ewing in 1921.
To this day it is the second most common bone tumor occurring in
children, adolescents and young adults, accounting for 10–15% of all
primary bone tumors (Burchill, 2003; Huvos, 1991). Clinical diagnosis
is usually conﬁrmed by imaging studies and histological analysis of
bone marrow and tumor samples (Fidelia-Lambert et al., 1999).
However, histological examination is limited by the lack of speciﬁcataBase; DSB, Double-strand
ene; ETS, E-twenty six; EWS,
mia virus integration 1; HCPA,
quilibrium; kb, Kilobase; mL,
formation; pb, Base pair; PCR,
osome; SNP, Single nucleotide
Disequilibrium Test; UFRGS,
nd Human Genetics, Faculty of
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sevier OA license.markers for Ewing's sarcoma cells. Clinically, any bone can be affected
by the sarcoma, but the most common sites are the lower extremities
(45%), followed by the pelvis (20%), upper extremities (13%), axial
skeleton and ribs (13%), and face(2%) (Burchill, 2003; Grier, 1997).
Roughly 88% to 95% of all Ewing's sarcoma cases are caused by a
translocation between the EWS gene (locus 22q12) and two ETS
transcription factors: FLI1 (11q24) or ERG (21q22) (Rerin, 2000;
Zucman-Rossi et al., 1997). The most common translocation involves
the EWS and FLI1 genes, which occurs in approximately 85% of cases,
followed by translocation between the EWSwith ERG gene, which oc-
curs in about 5–10% of cases (Delattre et al., 1992; Ozaki et al., 2002;
Sorensen et al., 1993; Zucman et al., 1993). Tumor development oc-
curs because the fusion between the EWS and FLI1 genes leads to
the formation of a potent and highly expressed aberrant transcription
factor. The chimeric EWS/FLI1 transcription factor is able to activate
the expression of various oncogenes (Jedlicka, 2010; Ludwig, 2008).
The EWS gene breakpoint is located usually between exons 1 and 7
(Burchill, 2003), a region in which a signiﬁcant number of single nu-
cleotide polymorphisms (SNPs) has been described. Bhagirath et al
(1995) sequenced the fusion genes EWS/FLI1 and showed that the
breakpoint in EWS occurred in an intronic region. In this region the
authors identiﬁed a palindromic hexamer 5′-GCTAGC-3′ which is
Table 2
Primer sequences used to amplify the targeted regions of single nucleotide polymor-
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common sequence of three nucleotides (GTC) at the fusion junction.
However, little is still known about the EWS gene breaking region.
We hypothesized that some sequences could promote a higher
susceptibility to chromosomal breakage. Here, we investigated SNPs
into the EWS gene breaking region in a healthy subjects' population
and in Ewing's sarcoma patients from Southern Brazil.
2. Materials and methods
2.1. Subjects
Our control population consisted of at least 200 healthy DNA do-
nors from Southern Brazil. Southern Brazil is composed by a singular
genetic background: most subjects are of European origin (Portuguese,
Italian, Spanish, and German ancestry) and a small amount of individ-
uals with African traits contribute to this genetic pool (Parra et al.,
2003; Pena et al., 2011). We also enrolled in this study 24 Ewing's sar-
coma patients (geographically matched with the control group) and 54
of their family members, including parents and siblings. This study was
approved by the institutional Ethics Committee (Protocol # 11/05424),
and informed consent was obtained from all participants.
2.2. Patient phenotyping
Ewing's sarcoma patients were diagnosed at the Pediatric Oncology
Unit of the UFRGS university hospital (HCPA). Of the 24 patients, 14
(58.3%) were female and 10 (41.7%) were male, with a median age of
11, ranging from 1 to 21 years old. Clinical diagnosis was conﬁrmed
by X-rays images, exploratory surgeries, or biopsies of muscle, tumor,
bone marrow and/or cerebrospinal ﬂuid obtained from lumbar punc-
ture. The majority of the tumors were located in the lower extremity
bones (45.8%) (Table 1).
2.3. Selection of SNPs
The selection of SNPs was based in three criteria: SNPs inside the
EWS gene break point region; SNPs that had been validated and/or func-
tionally tested; and SNPs described in the HapMap dbSNP (SNP Data-
Base — http://www.ncbi.nlm.nih.gov/snp) with a rare allele frequency
of ≥1% in populations of European or Caucasian ethnicity. From 294
EWS SNPs, we pre-selected 20 and submitted to the TaqMan® SNP
Genotyping Assays protocols (http://www.appliedbiosystems.com.br).
After further analysis of validation and SNP localization, we selected
three sequences as major candidate EWS SNPs: rs2301291 (intron 1,
G>A), rs4820803 (intron 3, G>C) and rs4820804 (intron 3, T>C).
2.4. EWS SNP genotyping
DNA was extracted from peripheral blood leukocytes following
the protocol of Lahiri and Nurnberger (1991). Genotyping was
performed by TaqMan® assay for allelic discrimination using a 7500
Real-Time PCR System (Applied Biosystems, Foster, CA., USA; Life
Technologies Corporation, USA) and analyzed using the allelic dis-
crimination endpoint analysis mode of the Sequence Detection soft-
ware package, SDS Version 1.3.1. We used a quality control systemTable 1
Bone affected by Ewing's sarcoma in the 24 patients studied.
Affected bones Patients [N (%)]
Lower extremities (7 femur; 1 ﬁbula; 2 tibia) 11 (45.8)
Pelvis 4 (16.7)
Upper extremities (2 humerus) 2 (8.3)
Axial skeleton and ribs (1 cervical spine; 4 chest) 5 (20.8)
Face (2 jaw) 2 (8.3)to ensure genotyping accuracy: sequencing veriﬁcation of ampliﬁed
DNA fragment, negative controls, and repetitions.
Sequencing was performed in 10% of the samples to ensure the re-
liability of the results obtained with the real-time PCR analysis. The
primers used to amplify the targeted regions were designed using
the Primer3 algorithm (http://frodo.wi.mit.edu/primer3) and are
presented in Table 2. Ampliﬁcation of samples was performed in
a ﬁnal volume of 25 μL, in a reaction containing 0.1–1 ng of DNA
in 1 μL, 12.5 μL of TaqMan Universal PCR MasterMix (Applied
Biosystems, Foster, CA, USA), 1 μL of 10 pmol/μL forward and reverse
primers and Milli-Q water. PCR was performed on Veriti Thermal
Cycler (Life Technologies Corporation, USA) using the following
conditions: denaturation at 95 °C for 10 min, followed by 34 cycles
of denaturation at 94 °C for 1 min, annealing at 60 °C for 30 s and ex-
tension at 72 °C for 30 s, with a ﬁnal extension at 72 °C for 5 min. PCR
products were puriﬁed using ethanol precipitation. Sequencing was
conducted under the BigDye™ terminator cycling conditions and
performed using an Automatic Sequencer ABI 3730XL (Applied
Biosystems, Foster, CA., USA; Life Technologies Corporation, USA).
2.5. Statistical analysis
Using Fisher's or Pearson's Chi-Square Test, we compared geno-
typic and allelic frequencies between groups, and tested the Hardy–
Weinberg equilibrium (HWE). Haplotypes were assembled using
Phase software v 2.1.1 (Stephens and Donnelly, 2003; Stephens et
al., 2001) and Arlequin software v 3.5.x (Excofﬁer and Lischer,
2010). For genotype comparisons between patients and control
group, we tested the three genotypes independently and combined.
For an association analysis, we tested all possible haplotype construc-
tions. Transmission Disequilibrium Test (TDT) was performed to de-
termine if there was a presence of genetic linkage between allelic
inheritance and Ewing's sarcoma. A p-valueb0.05 was assumed as
signiﬁcant in all tests conducted.
3. Results and discussion
Ewing's sarcoma is a rare disease with a frequency of 2–3 per
million in Caucasian populations in Western countries (Tortajada et
al, 2005). Given this information and the fact that the state of Rio
Grande do Sul has a population of 10.5 million people (IBGE Census
2010 — http://www.censo2010.ibge.gov.br/dados_divulgados/index.
php?uf=43), an incidence of 21–35 affected individuals in the state
is expected. We recruited 24 patients for this study. Therefore, even
though our sample number may seem low, it is in accordance with
the number of cases of Ewing's sarcoma expected to occur in the
state of Rio Grande do Sul.
We genotyped three SNPs in introns 1 and 3 of the EWS gene. All
SNPs were in HWE for the control group (p>0.05; Chi-Square Test).
Allelic and genotypic frequencies were calculated and compared
with those obtained by the HAPMAP project, and signiﬁcant differ-
ences were found (Table 3). The Southern Brazilian population is
known to have predominantly European inheritance as well as rarerphisms (SNPs) designed utilizing the Primer3 algorithm (http://frodo.wi.mit.edu/
primer3), expected annealing temperature, and expected amplicon size.




rs2301291 Forward: CGGGTGAGTATGGTGGAACT 60 °C 176 bp
Reverse: GGGGAGGGGAGAGGAATG
rs4820803 Forward: TGAGTGAACCAGATAAGGGATAAC 60 °C 198 bp
Reverse: CCATATGCCTGCTCCAAAAA
rs4820804 Forward: TGTTTTTGATTTTGGTTCTCCA 60 °C 179 bp
Reverse: CCCATAGGTTGCAGTGGTCT
Table 4
Genotype frequencies of rs2301291, rs4820803, and rs4820804 SNPs in patients with






rs2301291 AA+AG 102 (49.5) 12 (50.0) 0.86
GG 104 (50.5) 12 (50.0)
rs2301291 AG+GG 189 (91.7) 20 (83.3) 0.36
AA 17 (8.3) 4 (16.7)
rs4820803 CC+CG 66 (32.7) 9 (37.5) 0.81
GG 136 (67.3) 15 (62.5)
rs4820803 CG+GG 200 (99.0) 24 (100.0) 0.56
CC 2 (1.0) 0 (0.0)
rs4820804 CC+CT 144 (69.2) 10 (41.7) 0.02⁎
TT 64 (30.8) 14 (58.3)
rs4820804 CT+TT 174 (83.7) 18 (75.0) 0.45
CC 34 (16.3) 6 (25.0)
⁎ pb0.05.
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portant as a representative population sample, which allowed us to
know the frequency of each allele in the Southern Brazilian popula-
tion. The variability between the populations could be explained, at
least, due to geographic particularities (especially considering the
founder effect), or because of the reduced sample size investigated
(b1000 subjects). The particularities of each ethnic composition
(genetic background) could also be a factor to explain the differences
or similarities among the populations.
To investigate if some SNP or SNP-arrangement could have differ-
ent incidences in the affected individuals, we performed association
studies comparing genotypic frequencies of rs2301291, rs4820803,
and rs4820804 and all possible genotype combinations between
Ewing's sarcoma patients and the control group. The non-combined
analysis revealed a higher presence of homozygote T-rs4820804 in
Ewing's sarcoma patients (Table 4). A grouped analysis of all SNPs
(possible SNP-arrangements inheritance and/or haplotype combina-
tions) was performed to analyze if a combined heritage could present
a synergistic effect on the disease, but we could not detect a more im-
portant signiﬁcant result (all p>0.05; Chi-Square Test). Our ﬁndings
corroborate that of Dubois et al. (2011), in which there was a lack
of association between SNPs rs2301291 and rs4820803, and Ewing's
sarcoma. The authors analyzed both SNPs in a North American popu-
lation and did not ﬁnd any signiﬁcant results. In fact, we found that
the TT-rs4820804 EWS genotype was the only factor signiﬁcantly
higher in patients with the Ewing's sarcoma phenotype.
To examine if any SNP could have been preferentially inherited by
affected individuals, we performed a Transmission Disequilibrium
Test comparing data from Ewing's Sarcoma patients and from their
families. No statistically signiﬁcant result was found (individuallyTable 3
Allelic and genotypic frequencies of rs2301291, rs4820803 and rs4820804 SNPs in con-
trol subjects from Southern Brazil and comparison with data from the populations in-










rs2301291 N=206 N=226 N=226 N=258
AA 17 (8.3) 34 (15) 18 (8) 106 (41)
AG 85 (41.3) 116 (51.3) 86 (38) 124 (48)
GG 104 (50.4) 76 (33.6) 122 (54) 28 (11)
P b0.001 0.7621 b0.001
A 119 (29) 184 (40.7) 122 (27) 336 (65.1)
G 293 (71) 268 (59.3) 330 (73) 180 (34.8)
P b0.001 0.5356 b0.001
rs4820803 N=202 N=226 N=226 N=258
CC 2 (1) 6 (2.7) 19 (8.5) 16 (6.2)
CG 64 (31.7) 70 (31) 64 (28.4) 114 (44.2)
GG 136 (67.3) 150 (66.3) 143 (63.1) 128 (49.6)
P 0.4463 b0.001 b0.001
C 68 (16.8) 82 (18.1) 90 (19.9) 146 (28.3)
G 336 (83.2) 370 (81.9) 362 (80.1) 370 (71.7)
P 0.6147 b0.001 b0.001
rs4820804 N=208 N=226 N=226 N=258
CC 34 (16.3) 18 (8) 16 (7.1) 16 (6.2)
CT 110 (52.9) 104 (46) 60 (26.5) 114 (44.2)
TT 64 (30.8) 104 (46) 150 (66.4) 128 (49.6)
P b0.001 b0.001 b0.001
C 178 (42.8) 140 (31) 92 (20.4) 146 (28.3)
T 238 (57.2) 312 (69) 360 (79.6) 370 (71.7)
P b0.001 b0.001 b0.001
a Submitter Population Handle/ID: CSHL-HAPMAP/HapMap.
b We considered both Asian populations HapMap-HCB (N=86) and HapMap-JPT (N=
172). All comparisons were made between control versus HAPMAP population by Pearson's
Chi-Square Test (for more information about HAPMAP, please visit: http://www.ncbi.
nlm.nih.gov/projects/SNP/snp_ref.cgi?rs=2301291, http://www.ncbi.nlm.nih.gov/projects/
SNP/snp_ref.cgi?rs=4820803; and http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?
rs=4820804).rs2301291: p=0.749; rs4820803: p=0.759; rs4820804: p=0.274;
Transmission Disequilibrium Test).
Complex diseases like Ewing's sarcoma are caused by many intrin-
sic (genetic) and extrinsic (environmental) factors, and each factor
alone has somewhat of an effect. To search for candidate genetic
markers to understand a complex disease is like looking for a needle
in a haystack. Even though we have studied a single segment of the
EWS gene, it showed a very important result in the Ewing's sarcoma
scenario; the effect of the TT-rs4820804 EWS genotype can be small,
but it was strong enough to appear as a signiﬁcant factor in our
population.
Ewing's sarcoma and many other cancers are caused by transloca-
tions resulting in fusion genes. However, little is known about why or
where chromosomes break. Blitzblau et al (2007) mapped meiotic
double-strand breaks (DSBs) in budding yeast and showed that
DSBs do not appear randomly, but occur most frequently in a speciﬁc
band near telomeres and at high rates around the centromere.
According to Gao et al. (2005), genetic studies in yeast have revealed
that the breaking hotspots contain special sites for recombination ini-
tiation, and result in a heterogeneous distribution of recombination
(along the chromosome length or across the genome). In humans,
more knowledge concerning the hotspots for chromosome breakage
could aid in better understanding certain aspects in cancer. We be-
lieve that the presence of a particular SNP or the combination of dif-
ferent SNPs in a certain sequence could make a region more fragile
and prone to a chromosome break. The rs4820804 SNP is a common
and non-functional polymorphic variation that might be near a
breakpoint region. Bhagirath et al (1995) sequenced the fusion
genes EWS/FLI1 and identiﬁed the breakpoint in EWS in an intronic
region. The authors observed the presence of a palindromic hexamer
(5′-GCTAGC-3′) and a common three-nucleotide sequence (GTC) in
the close vicinity of the breakpoint junction in both EWS and FLI1.
The presence of the palindromic hexamer ﬂanking the breakpoint re-
gion was considered the most intriguing ﬁnding since palindromes
may serve as speciﬁc recognition sites for DNA-binding proteins or
restriction enzymes. This palindrome may have a functional signiﬁ-
cance in the genesis of the t(11;22) translocation (Bhagirath et al.,
1995; Warren and Green, 1985). We analyzed the genomic context
of the rs4820804 SNP and found the same palindromic hexamer
(5′-GCTAGC-3′) and the same three nucleotides (GTC) about 300 bp
from the SNP (Fig. 1). The DNA segment surrounding the rs4820804
SNP is likely a candidate for a breakpoint region.
Analyzing the results, the TT-rs4820804 genotype could be associ-
ated, even if not directly, with a higher propensity of EWS breakage
or to a EWS/FLI translocation. In theory, one single chromosome change
(heterozygosis) would be enough to lead to a translocation between
the EWS and ETS genes; we call attention to the fact that we did not
ﬁnd a higher frequency of rs4820804 heterozygosis in patients affected
Fig. 1. Sequence context of the rs4820804 SNP (boxed) in intron 3 (GI|224589814:29663998–29696515). The palindromic hexamer 5′-GCTAGC-3′ is underlined once and the three
nucleotides (GTC) are underlined twice.
266 D.S.B.S. Silva et al. / Gene 509 (2012) 263–266by Ewing's sarcoma. If the T-rs4820804 allele could make a region frag-
ile and predisposed to breakage, homozygotes (TT-rs4820804) would
have doubled the chance to have a chromosomal breakage, increasing
the chances for a translocation to occur. We can suggest the SNP
rs4820804, in its genomic context, as a candidate marker to help
understand the susceptibility for Ewing's sarcoma.
4. Conclusion
The present study provides statistically founded evidence that the
TT-rs4820804 EWS genotype is associated with Ewing's sarcoma.
Moreover, this polymorphism and its genomic context can provide
insights into the EWS chromosome breakage context of tumorigenesis.
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